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INTRoDUcTIoN
In 2005, colorectal cancer (CRC) was listed as the third most commonly diagnosed cancer and second most common cause of cancer deaths in the US. The 5-year survival rate for localized disease is 90%, but deteriorates to 67% for regional staging and 0% in distant metastasis; between 995 and 2000, only 39% of patients diagnosed with CRC had localized disease. Early CRC often has no symptomology and the infrequently presenting manifestations are non-descript and ambiguous, including rectal bleeding, bloody stool, change in shape of stool and lower abdominal cramping with urges for unnecessary bowel movements.
Current screening tools for CRC include digital rectal exams, fecal occult blood tests, flexible sigmoidoscopy, colonoscopy, and Barium enemas with air contrast. Well-regarded as the gold standard of CRC screening, colonoscopy is considered to have the highest accuracy in detecting cancer; however, colonoscopy only provides a surface topography of the colonic mucosa, with a reported sensitivity of 76.7%, 2, 3 and can often overlook small polyps and cancers. More accurate methods of CRC detection are needed to diagnose earlier, localized stages of disease.
Mouse models of human disease are frequently utilized to evaluate diagnostic tools, therapeutics, and the underlying pathologic progression of diseases due to their anatomic homology and effective, accurate modeling of human pathology. Currently, over 30 mouse models of intestinal cancer are available, 4 encompassing chemically induced models, genetically engineered models and xenograft models. 5 A commonly used chemically induced rodent model of CRC is the azoxymethane (colon-specific carcinogen, AOM) treated mouse. It has long been known that the procarcinogen, ,2-dimethlyhydrazine (DMH), induces CRC in rodents when metabolized into the carcinogenic alkylating ion methyldiazonium. Azoxymethane (AOM), an intermediate compound in this metabolic pathway also acts as a colorectal procarcinogen, 4 inducing large numbers of aberrant crypt foci (ACF) in the distal colon of mice. 6 First described by Bird et al. in rodents treated with AOM, 7 ACF are small foci of elongated crypts with a thickened layer of epithelial cells, slit-shaped luminal opening and increased pericryptal space often visualized with methylene blue staining. 4 ACF are thought to be preneoplastic lesions preceding the development of colorectal adenomas and adenocarcinomas. 8 Of the large number of ACF expressed in response to AOM carcinogen, a fraction of the lesions progress to adenoma/adenocarcinomas, permitting AOM-induced CRC mouse models to be utilized to emulate non-familial CRC in humans. 9 The inbred A/J mouse strain has previously been found highly susceptible to the effects of AOM. With approximately 20 ACF per cm of colon and ten tumors per colon in AOM treated A/J mice just nine weeks after the final dose of AOM, this model and mouse strain are ideal for the study of CRC. 6 Colonic endoscopy has been performed in mouse models of colorectal cancer and inflammatory bowel disease, including a pilot study of serial white light endoscopy using a pediatric cystoscope 0 and a serial study of high resolution chromoendoscopy applying topical methylene blue for identification of ACF. Fluorescence endoscopy has been utilized to evaluate affinity of fluorescent ligands derived from library screens in orthotopic colonic tumors. 2 Fluorescence imaging of protease expression and vascularity in mouse models of adenomatous polyps and orthotopically-implanted cancer was evaluated using multi-channel microendoscopic imaging. 3 Optical coherence tomography (OCT) is a relatively new imaging technology with micron-scale resolution that has been evaluated in an assortment of applications, including in vivo imaging of the human colon and rectum. It has been shown to detect adenoma and carcinoma of diseased human colon. [4] [5] [6] [7] This highly sensitive, minimally invasive, non-destructive imaging modality uses near-infrared light backscattered from index of refraction changes to create highresolution cross-sectional images. Since the contrast is generated by intrinsic physiological reflective properties of tissue, gas insufflation or exogenous dyes as in absorption imaging is not needed. OCT can be adapted for fiber based endoscopic applications with relative ease, including miniaturization for small diameter applications. Recently, advances in OCT have provided imaging speeds orders of magnitude faster than conventional OCT, allowing for comprehensive imaging of porcine esophageal mucosa and coronary arteries acquired in vivo through flexible, narrow-diameter catheters. 8 Previously, we studied the use of standard resolution (~5 mm) endoscopic OCT to evaluate the lower colon and rectum of the C57BL/6J-Apc Min mouse model of CRC in vivo over time and found standard resolution OCT capable of visualizing the progressive mucosal thickening and structural organization loss characteristic of adenoma development. However, the relatively coarse resolution was inadequate to visualize the minute structural details of the colon, such as the mucosal crypts, which are considered to be the initial origin of ACF and colonic neoplasms. Limited resolution also made it difficult to differentiate confounders such as lymphoid aggregates and fecal material from neoplasms. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] We expected that a higher resolution device would be able to visualize these structures. An ultrahigh resolution (UHR) OCT endoscope with 5 mm resolution in air has been developed and utilized to perform in vivo imaging in rabbit colon. 2 We recently developed a custom UHR time domain OCT endoscope fabricated specifically for the small proportions of the murine colon and achieving the highest resolution in OCT endoscopy to date. 22 In this study, we utilized the UHR OCT endoscope to image the lower colon of AOM treated A/J mouse models of CRC over time, monitor the progression of neoplastic transformations, determine if OCT is capable of identifying the early stages of colorectal disease in mouse models, and evaluate whether pathological interpretation of OCT images parallels histopathological diagnosis.
MATERIALS AND METHoDS
Endoscopic UHR-OCT system. The novel achromatized endoscope design has been previously described in detail, 22 as has the UHR OCT system. 23 Briefly, ultrahigh-resolution is achieved axially using a mode-locked Titanium:sapphire laser with a full-width-halfmaximum bandwidth of 50 nm, centered at 800 nm, and transversally by utilizing : conjugate imaging of a small core diameter fiber. The endoscope provided axial and lateral resolutions of 3.2 and 4.4 mm, respectively, as measured in air. Figure presents a schematic of the OCT system used in this study.
Light from the source was split by a fiber-based 2 x 2 coupler into two paths: one path traveled to the endoscope where light was focused onto the tissue and the other traveled to the reference arm, which consisted of a high speed longitudinally scanning reference mirror (up to 250 Hz, 400 mm/s). Interference occurred when the optical pathlengths of light backscattered from the sample and light reflected from the reference mirror were within the coherence length of the source. By moving the reference mirror, backscattered light from various depths in the sample interfered, producing a full depth scan during a mirror oscillation. At the tip of the sample arm, a 2.0 mm outer diameter endoscope housed the OCT fiber, associated optics and achromatizing doublet lenses. A tilted front-surface mirror was used to direct light laterally to the endoscope longitudinal axis. By translating the inner lumen of the endoscope containing the focusing optics inside the outer lumen connected to a sealed window tip between depth scans, a two-dimensional image was acquired. Longitudinal images were obtained of the distal 30 mm of the colon at 6 angular positions (separated by 22.5°). The depth of the images was 0.7 mm at the first two imaging timepoints and .3 mm at the last two imaging timepoints (depth was increased to accommodate thickening in the colonic mucosa). The interferometric data contained 64 k sample points, that where reduced to k intensity points, corresponding to the local amplitude of the signal envelope. Data were acquired at mm/s. The images were equalized in intensity and the local signal loss, due to absorption was partially compensated by a digital image processing filter.
Animals. Eighteen AOM treated A/J (weight range: 7.0-20.4 g) and four control A/J (8.0-2. g) mice were originally included in the study. Mice were purchased from Jackson Laboratories (Bar Harbor, ME). All mice were housed by the University of Arizona Animal Care in microisolators on a 2:2 hr light/dark cycle with free access to water and standard laboratory chow during AOM treatment and post-treatment periods. During the imaging period, mice were housed by the Medical University of Vienna in similar conditions. Protocols were approved by the University of Arizona Institutional Animal Care and Use Committee and the Medical University of Vienna Animal Use Committee. Thirteen treated and two control mice completed the study.
AOM treatments.
The AOM treated A/J mice were treated with 0 mg/kg of azoxymethane purchased from Sigma-Aldrich Chemicals (St. Louis, MO) subcutaneously once a week for five weeks, starting at seven weeks of age. Control mice were given s.c. saline injections of equivalent volume following the same schedule. The mice were then allotted an 8-week period following the final AOM treatment to allow disease development prior to the initial imaging timepoint.
Imaging procedure. Figure 2 depicts the progression of our study, including treatment and imaging timepoints. Mice were imaged with OCT at 8, 4, 22 and 26 weeks post AOM treatment (corresponding to timepoints -4, respectively) or until death. During each imaging timepoint, mice were fasted for 2 hours prior to imaging and anesthetized during imaging with a mixture of Ketamine (0.33 mg/ml, 00 mg/kg) and Xylazine (0.033 mg/ml, 0 mg/kg), administered intraperitoneally. The endoscope was coated with a biocompatible water-based lubricant and inserted into the anus with the mouse in the dorsal supine position. A survey of the colon was acquired within 20 minutes of anesthesia by sequentially taking 30 mm longitudinal scans at sixteen rotations (22.5° increments, starting at 0° corresponding to ventral colon).
Tissue acquisition and histology. Following the final imaging timepoint, the mice were euthanized with an overdose of a mixture of Ketamine (0.33 mg/ml) and Xylazine (0.033 mg/ml) and the colorectal tissue was excised for histology. A 2 mm diameter Pyrex glass rod was inserted into the anus to replicate endoscope insertion and the abdominal cavity of the mouse was opened. A depth scale marked on the glass rod was visible through the colon wall and was used to guide marking the imaging depth and the 0° rotation (ventral) on the abluminal side of the colon with black permanent marking dye (Polysciences, Warrington, PA). The colon and rectum were opened longitudinally, adhered flat to Whatman paper and fixed in an alcohol-based fixative (Histochoice, Amresco, Solon, OH). Tissues were then processed, embedded in paraffin, and sectioned. Longitudinal sections were obtained at locations corresponding to each rotation of the imaging endoscope, and were stained with hematoxylin and eosin. Tissues were interpreted by a board-certified veterinary pathologist according to accepted criteria for mouse colon cancer models. 4 Diagnostics and statistical analysis. For both the treatment and control groups, eight of 6 images obtained per colon from each mouse and each timepoint were chosen for analysis (46 total images). A panel of three experts in mouse colorectal pathology examined the OCT images. Using a set of diagnostic criteria determined from a separate training set (35 images) of OCT data (Table ) , the panel identified and diagnosed regions of gastrointestinal neoplasia (GIN) and adenoma. All remaining undiagnosed regions of the OCT images were assumed to be normal. Histological sections evaluated by the pathologist served as the gold standard.
Disease identified in the final OCT imaging timepoint and histopathology were compared, with a match defined as corresponding diagnoses in OCT and histology occurring within defined longitudinal (±3 mm) and rotational (±45°) tolerances. Tolerances were set to accommodate non-uniform stretching of the colon during imaging procedures and inaccuracies during histological processing. Sensitivity was determined for both diagnosis-specific classification and general disease identification. As all undiagnosed regions were classified as normal tissue by default in both OCT and histology evaluations, specificity was not calculated but was estimated based on control mouse samples and disease false positive rates. Disease progression over OCT imaging timepoints was evaluated using a trend analysis.
RESULTS
Of the 8 treatment and four control mice that began the study, 3 treatment and two control mice survived the entire study and were imaged at all four timepoints with no technical problems with OCT (Table 2 ). Of these 3 treatment mice, the colon samples from two mice had data that was not analyzable by histology, thus they were removed from the analysis. Of the remaining treatment mice, some individual OCT/ histology pairs were excluded from analysis if () low signal intensity compromised analysis of the OCT image (.7% of total OCT images), (2) over 50% of colonic tissue in the OCT image was out of the field of view due to contractions of the muscularis propria (8.%) or fecal pellets displacing the colon Determined from a training set of 35 OCT images, the panel identified and diagnosed regions of gastrointestinal neoplasia (GIN) or adenoma based on the following criteria. All remaining undiagnosed regions of the OCT images were defaulted normal. from endoscope (.8%) or (3) corresponding histological sections were incomplete and analysis was not feasible (25% of histopathology).
Characteristics of normal and neoplastic colon in OCT. Figure 3 shows two 8 mm segments of an OCT image from a control mouse at timepoint 4, from the distal colon (A) and the rectum/anus (C) together with their corresponding histological sections (B and D, respectively). The typical layered structure of the GI tract is visualized in the histological section of distal colon (Fig. 3B ). Both the layers and layer boundaries were visualized with OCT (Fig. 3A) . The mucosa (M) is visible as a distinct layer of consistent thickness, moderate signal intensity due to tissue related scattering properties, and consistent signal attenuation (Table ) . A vertical texture can be visualized in the mucosa that appears to correspond to the crypt structure characteristic of colonic mucosa. This texture is inconsistently present both within an individual OCT image and over the collection of OCT images obtained in this study. Below the mucosa is a bright boundary corresponding to the refractive index mismatch between the muscularis mucosa and the submucosa. Below this boundary, a thin hypointense layer is seen corresponding to the submucosa. The abluminal edge of the submucosa is terminated in a second bright boundary corresponding to the index mismatch between the submucosa and muscularis propria. A lymphoid aggregate is seen as a hypointense region within the submucosa. The muscularis propria appears as a hypointense layer underlying the submucosa/ muscularis propria boundary. Occasionally, the circular and longitudinal muscle layers can be differentiated, with the longitudinal muscle appearing as a thin, hypointense region below the more signal rich circular muscle. A final bright boundary underlies the muscularis propria corresponding to the index mismatch between the muscularis and the adventitia.
In the rectum and anus (Fig. 3D) , histology reveals a transition in epithelium from simple columnar to stratified squamous. Both layers of the muscularis propria become significantly thickened and form the anal sphincter. OCT imaging of the rectum and anus (Fig. 3C) displays a conversion from a characteristic moderately intense mucosa to a thinner, highly backreflecting mucosa, marking the epithelial transition. The muscularis propria thickens significantly as it approaches the anal region and then tapers to form the anal sphincter.
An adenoma imaged by OCT (Fig. 4A ) is typically characterized by a moderately to markedly protruding mucosa. With depth through the lesion, a moderate to marked attenuation of signal is visualized when compared with normal mucosal attenuation. Resulting from this increased signal attenuation, the tissue boundaries underlying the lesion are no longer visible due to the minimal amount of light penetrating through the depth of the adenoma (Table ) . Corresponding histopathology confirms the presence of an adenoma (Fig. 4B) .
OCT images of GIN, which is an earlier form of colorectal neoplasia (Fig. 5A) , are typically seen as small lesions (<few mm), ranging from a mucosal thickening (~2x normal mucosal thickness) to a mild protrusion (<50% total thickness). Signal attenuation with depth over the GIN is mildly increased and as a result, the underlying tissue boundaries are faint but visible when compared with normal colon (Table ) . Corresponding histopathology presented confirms the presence of the GIN (Fig. 5B) .
Comparison of final timepoint OCT image and histopathologic classifications. Diagnoses assigned to the final timepoint OCT images by the blinded panel were compared with histopathologic diagnoses. All final timepoint OCT images of control mice were Figure 2 . Time course of study. AOM treatment was administered for five weeks starting at seven weeks of age, followed by an eight-week period to allow initial disease development. Mice were imaged with OCT at 8, 14, 22 and 26 weeks post AOM treatment. After the last imaging timepoint, the mice were euthanized and the colon was harvested for processing and H&E staining. TP, timepoint; Tx, treatment. Histological artifact n/a n/a n/a 50 50 34.2% n/a Total 146 100.0% 11.6%
Of the 13 treatment mice that survived the study, colon samples from 2 mice had non-analyzable histology, thus they were removed from the analysis. Of the remaining 11 treatment mice, individual OCT/histology pairs were excluded from analysis if low signal intensity compromised analysis of the OCT image, over 50% of colonic tissue in the OCT image was out of the field of view due to contractions of the muscularis propria or fecal pellets displacing the colon from endoscope, or corresponding histological sections were incomplete and analysis was not feasible. A total of 832 OCT images and 208 histopathology slides were collected in this study.
No.: number, TP: time point, Ctrl: control, FOV: field of view.
correctly identified as normal. Table 3 displays the number of true positives, false negatives, false positives, and sensitivity for adenoma and GIN. Out of 40 total adenomas identified in histology, 38 were correctly classified by the panel resulting in a sensitivity of 95%. The two unidentified adenomas could not be located in the OCT images. There were seven instances of adenomas incorrectly diagnosed in the OCT images by the panel; six of these seven false positives were GINs misdiagnosed as adenomas and one of seven false positives was of a histologically unidentifiable origin. Out of 44 histologically identified GINs, 0 were correctly classified in OCT by the panel, for a sensitivity of 23%. From the 34 false negative GINs, nine were misdiagnosed as adenomas and 25 were not identified. There were four instances of GINs identified by the panel in OCT that were of histologically unidentifiable origin. When the 44 GINs were stratified into either protruding (2) or nonprotruding (23) GIN based on histological structure, the resulting sensitivity for protruding GINS was 38% and non-protruding GINs was 9%.
Overall, a total of 84 disease foci (40 adenoma and 44 GIN) were histologically identified and 57 (38 adenoma and 9 GIN: 6 protruding and 3 non-protruding) were correctly identified in OCT as disease, resulting in an overall sensitivity to any disease of 68%. Sensitivity to more advanced disease foci (adenomas and protruding GIN) were 95% and 76%, respectively.
Analysis of disease progression in OCT over time. An example OCT image series over the four time points along with final timepoint histology is presented in Figure 6 . In timepoint (Fig. 6A) , the disease foci appears as a mucosal thickening with a small lateral dimension (<few mm). The signal attenuation through the foci is increased and the underlying boundaries are faint when compared to adjacent normal colon. The lesion displays characteristics most consistent with GIN. In timepoints 2 and 3 ( Fig. 6B and C, respectively) , the disease foci are enlarged to a moderate protrusion with larger lateral dimensions (>few mm). The signal attenuation is moderate with markedly faint tissue boundaries underlying the disease foci, most consistent with the criteria for adenoma. In the final timepoint (Fig. 6D) , there is marked signal attenuation over the disease foci and the underlying tissue boundaries are absent, again consistent with the criteria for adenoma. The corresponding histological section confirms the presence of an adenoma at the appropriate location (Fig. 6E) .
The total number of disease foci diagnosed in OCT over all imaging timepoints is presented in Figure 7 , along with histopathologically confirmed disease. The analysis showed an increase in OCT-detected adenoma over time, with only a small increase in OCT-detected GIN.
Diagnoses from OCT images were compared over timepoints 2, 3 and 4 at the locations corresponding to the 38 adenomas and 0 GINs identified by OCT and histologically confirmed in the final timepoint. Due to the lack of positive identification of some mice at the first imaging timepoint, only the last three timepoints are included in this analysis. The expected progression of normal and/or GIN OCT diagnosis preceding adenoma OCT and/or histopathologic diagnosis was generally evident. Of the ten histologically confirmed GINs in the final timepoint, all were preceded by GIN or normal tissue in the earlier timepoints. The vast majority of the 38 histologically confirmed adenomas displayed the expected progression of disease over time by OCT. However, one mouse deviated from this progression, displaying three adenomas in timepoint 4 and one adenoma and two GINs in the corresponding locations in timepoint 2; however these locations in the intervening timepoint 3 were diagnosed as and appeared normal. Regions of the AOM treated mice classified and histologically confirmed as normal in the final timepoint were generally preceded in the earlier timepoints by normal classifications in the corresponding regions. Exceptions to this are three 2 mm regions diagnosed as GINs, one in timepoint 3 and two in timepoint 2, that were classified as normal in the final timepoint.
All OCT images of the control mice were diagnosed as normal in the final OCT imaging timepoint. However, in the earlier timepoints, two mm regions were identified as GIN. A complete summary is shown in Figure 8 .
DIScUSSIoN
In the comparison of final timepoint OCT and histopathological diagnosis, the OCT sensitivity for adenomas was found to be quite high (95%), with few false negative and false positive results. Both of the false negative adenomas were small lesions and it is possible they were missed due to imperfect matching between OCT images and histology sections. Of the seven OCT false positive adenomas, six were misdiagnosed protruding GINs. Only one false positive adenoma was of a histologically unidentifiable source, and may also be due to imperfect OCT/histology matching.
A major challenge of the study was acquiring OCT images at the same locations for all imaging timepoints and obtaining histological sections corresponding to these exact locations. Protocols were developed to optimize OCT image and histology matching, however the following may have contributed to imperfections in matching: () Colonic elasticity allows the colon to stretch and encompass the endoscope; large adenomatous masses may result in a mild deformation of the colon around the endoscope, skewing the OCT imaging locations as the lesions grew larger over the imaging timepoints. (2) The presence of the endoscope within the rectum of the mouse often stimulates contraction of the muscularis propria, resulting in mild displacements of the colon that may have disrupted consistent OCT imaging at the same locations over the timepoints. (3) Due to the high degree of difficulty in obtaining histological sections at the precise location of OCT imaging, smaller dimension lesions such as GINs or small adenomas may have been sampled by one modality but not the other possibly contributing to the false positive and negative counts in the OCT evaluation. (4) Histological fixation and processing protocols are known to cause tissue samples to shrink and distort.
The OCT sensitivity for GIN was considerably lower (23%) than adenoma sensitivity. When the GINs were stratified by presence or absence of protrusion in histopathology greater than the normal mucosal thickness, it was found that the non-protruding GIN sensitivity was low (9%) and the protruding GIN sensitivity was considerably higher (38%). Non-protruding lesions tended to be small and did not have a marked thickening in comparison to normal mucosa or protuberance into the lumen. It is possible that if more emphasis were placed on identifying signal attenuation changes and/or boundary faintness that more GINs could have been identified, however, these features can be difficult to differentiate from normal mucosal variance and thus make identifying these lesions more challenging. Automated detection based on attenuation differences may be a possibility to improve GIN detection. Additionally, the small lateral dimension typical of GINs makes their identification more reliant on accorded OCT/histology matching.
In 38% of cases, protruding GINs were misdiagnosed adenomas. These findings suggest that improved criteria to better differentiate protruding GINs and adenomas should be developed, with an emphasis on a more quantitative evaluation of the degree of protrusion and/or lateral dimension of the lesions. In addition, it is recognized that aberrant crypt foci, non-protruding GIN, protruding GIN, adenomas and adenocarcinoma are thought to form a continuum of the progressive stages of colorectal cancer. As a result it can be difficult to definitively classify histologic lesions that border two stages in this progression, such as advanced GIN and early adenoma, although the accepted criteria for histologic classification of these lesions were applied during this study. 4 Regions of the AOM treated mice classified and histologically confirmed as normal in the final timepoint were generally preceeded in the earlier timepoints by normal classifications in the corresponding regions. Exceptions to this are three 2 mm regions Criteria were developed for lymphoid aggregates (submucosal and mucosal) and fecal contamination. The blinded OCT panel was trained to differentiate these features from neoplasms. LA, lymphoid aggregate; FOV, field of view. diagnosed as GINs, one in timepoint 3 and two in timepoint 2, that were classified as normal in the final timepoint. In the trend analysis, unexpected progression may have resulted from imperfect matching between OCT and histopathology causing disease (or greater severity of disease) to be visualized in earlier timepoints, but not the final timepoint. It is also possible that apparent lesions were actually mild diffuse inflammation seen in the AOM treated mice, which is capable of causing a mild thickening of the mucosa and possibly acting as a false positive confounder for GIN diagnosis. A third less likely possibility is that the GINs, as defined by dysplastic tissue, are capable of regression in their earlier stages; 24 the small disease foci may have existed in the timepoints in which they were classified, but regressed to normal tissue prior to the subsequent imaging timepoint.
All OCT images of the control mice were diagnosed as normal in the final OCT imaging timepoint. However, in the earlier timepoints, two mm regions were identified as GIN. Both of these regions displayed mild characteristics of GIN, but were within the range of normal mucosal variation. This illustrates the potential difficulty of differentiating smaller GIN lesions with milder characteristics from the typical variations of normal tissue; however, the infrequency of this difficulty in this study is encouraging. Its occurrence may be alleviated with improved diagnostic criteria, such as quantifications of mucosal thickness ranges constituting normal mucosal variation versus GIN.
Due to the classification of normal tissue by default, specificity was not determined for this dataset because of the inability to precisely quantify the number of true negatives. However, the data suggest that specificity should be high due to: () classification of all final timepoint control mice OCT images as normal, (2) low false positive count of histologically unidentifiable lesions for both adenoma and GIN in the final timepoint and (3) low number of disease foci identified in prior timepoints at locations histologically confirmed normal in the final timepoint.
An additional challenge of the study was to differentiate neoplasms from non-neoplastic features of the colon that displayed similar characteristics as neoplasms, including lymphoid aggregates (submucosal and mucosal), fecal contamination and mild diffuse inflammation exhibited by the AOM treated mice. To accomplish this, criteria were developed for these features and the blinded OCT panel was trained to differentiate these features from neoplasms (Table 4) . Submucosal lymphoid aggregates were characterized as well-circumscribed hypointense regions located under the mucosa with visible tissue boundaries (Fig. 9A and B) . In contrast, mucosal lymphoid aggregates were located within the mucosa as normal to mildly thickened hypointense regions with poorly defined borders that tended luminally at the edges of the aggregate. Tissue boundaries underlying the mucosal lymphoid aggregates were visible despite the hypointensity of the overlying aggregate ( Fig. 9C and D) . Fecal contamination, most commonly in the form of pellets, was visualized as supramucosal masses with hyperintense surfaces and marked signal attenuation. Often the tissue boundaries underlying feces were out of the FOV (Fig. 9E) . The features of mild diffuse inflammation generally fell within the criteria encompassing the normal variation of the colon and thus separate criteria were not developed for this condition. In the final timepoint OCT, there were no instances in which a lymphoid aggregate or fecal pellet was identified as a neoplasm, indicating the criteria implemented to differentiate these confounders from neoplasms are sufficient. The low instance of false positives indicate that the mild diffuse inflammation was also not a large confounder in this study, however, criteria to differentiate inflammation from GIN may aid in further decreasing the number of false positive GINs.
coNcLUSIoNS
UHR OCT enables accurate identification and diagnosis of adenomatous lesions, identification of protruding GIN and nondestructive visualization of CRC progression in the lower colon of mice. Therefore, UHR-OCT endoscopy may provide a valuable tool for cancer research by monitoring disease progression and/or effects of experimental drugs and therapies in animal models. Future studies will include improved protocols for OCT image/histology correlation, higher imaging speeds with UHR frequency domain OCT, increased rotational sampling in OCT and histology and larger sample numbers with animal sacrifice at intermediate timepoints to fully assess the significance of findings in this study.
